US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Mesabi

22.77

-0.3800-1.64%

Post-market: 22.900.1300+0.57%16:15 EDT

Volume:142.33K

Turnover:3.24M

Market Cap:298.74M

PE:26.38

High:23.49

Open:23.16

Low:22.42

Close:23.15

52wk High:42.38

52wk Low:21.60

Shares:13.12M

Float Shares:13.11M

Volume Ratio:5.17

T/O Rate:1.09%

Dividend:0.89

Dividend Rate:3.91%

EPS(TTM):0.8632

EPS(LYR):1.06

ROE:59.68%

ROA:28.92%

PB:16.29

PE(LYR):21.54

Loading ...

Overview Company News Filings

The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman

The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman

MT Newswires Live

Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L

Simply Wall St.

Mesabi Trust Reports Higher Shipments But No Bonus Royalties

Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?

Simply Wall St.

Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain

Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives

Simply Wall St.

Mesabi Trust publishes fiscal 2026 annual report

Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil

Simply Wall St.

Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline

Simply Wall St.

Press Release: Mesabi Trust Press Release

Did FDA-Cleared Duchenne Trial for Ryoncil Just Shift Mesoblast's (ASX:MSB) Investment Narrative?

Simply Wall St.

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION

Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation

Is Mesoblast (ASX:MSB) Offering Value After Recent Share Price Declines?

Simply Wall St.

Macquarie Group Rise After Financing Mesabi's Minnesota Iron Ore Mine

MT Newswires Live

Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

Airwallex Secures Dual Licenses for E-Money and MSB Class A Operations in Malaysia

Press Release: Mesabi Metallics Secures $520 Million from Breakwall Capital - Advances towards Q3 2026 start of New American Iron Ore Mine

Mesoblast (ASX:MSB) Valuation Check As First R&D Day Puts Pipeline And Growth Plans In Focus

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/MSB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MSB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB\",,,,,undefined,":{"symbol":"MSB","market":"US","secType":"STK","nameCN":"Mesabi","latestPrice":22.77,"timestamp":1787342400000,"preClose":23.15,"halted":0,"volume":142328,"hourTrading":{"tag":"盘后","latestPrice":22.9,"preClose":22.77,"latestTime":"16:15 EDT","volume":56108,"amount":1277641.44,"timestamp":1787343300138,"change":0.13,"changeRate":0.005709,"amplitude":0.005709},"delay":0,"changeRate":-0.016414686825053953,"floatShares":13109915,"shares":13120010,"eps":0.863187,"marketStatus":"Market Closed","change":-0.38,"latestTime":"08-21 16:00:00 EDT","open":23.1604,"high":23.49,"low":22.42,"amount":3241139,"amplitude":0.04622,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.863187,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":23.15,"dividendRate":0.039087,"preHourTrading":{"tag":"盘前","latestPrice":23.15,"preClose":23.15,"latestTime":"04:00 EDT","volume":3,"amount":69.44999999999999,"timestamp":1787299210760,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":22.9,"preClose":22.77,"latestTime":"16:15 EDT","volume":56108,"amount":1277641.44,"timestamp":1787343300138,"change":0.13,"changeRate":0.005709,"amplitude":0.005709},"volumeRatio":5.169435524321842,"impliedVol":0.6602,"impliedVolPercentile":0.7888},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB\",,,,,undefined,":{"symbol":"MSB","floatShares":13109915,"roa":"28.92%","roe":"59.68%","lyrEps":1.057069,"volumeRatio":5.169435524321842,"shares":13120010,"dividePrice":0.89,"high":23.49,"amplitude":0.04622,"preClose":23.15,"low":22.42,"week52Low":21.6,"pbRate":"16.29","psRate":"19.87","week52High":42.38,"institutionHeld":0.5084,"latestPrice":22.77,"eps":0.863187,"divideRate":0.039087,"volume":142328,"delay":0,"ttmEps":0.863187,"open":23.1604,"prevYearClose":38.52,"prevWeekClose":22.96,"prevMonthClose":21.99,"prevQuarterClose":25.3,"fiveDayClose":22.96,"twentyDayClose":22.5,"sixtyDayClose":26.3,"dividendPayoutRate":1.210895409854986,"dividendFrequency":"Q","dividendGrowthYears":0,"dividendGrowthRate":-0.8152958152958153,"fiveYearAvgDividendRate":0.11271347852028439},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB\",params:#limit:5,,,undefined,":[{"date":"2026-07-30","symbol":"MSB","amount":0.05,"announcedDate":"2026-07-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-30","defaultRemindTime":1785418200000,"name":"美莎比信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-20","payableDate":"2026-07-30","currency":"USD","dateTimestamp":1785384000000,"payDate":"2026-08-20"},{"market":"US","date":"2026-06-12","symbol":"MSB","fiscalQuarterEnding":"2026/04","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1781236800000,"reportTimeType":"post","actualEps":0.08},{"date":"2026-04-30","symbol":"MSB","amount":0.24,"announcedDate":"2026-04-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-30","defaultRemindTime":1777555800000,"name":"美莎比信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-20","payableDate":"2026-04-30","currency":"USD","dateTimestamp":1777521600000,"payDate":"2026-05-20"},{"market":"US","date":"2026-04-22","symbol":"MSB","fiscalQuarterEnding":"2026/01","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1776830400000,"reportTimeType":"post","actualEps":0.21},{"date":"2026-01-30","symbol":"MSB","amount":0.26,"announcedDate":"2026-01-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-30","defaultRemindTime":1769783400000,"name":"美莎比信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-20","payableDate":"2026-01-30","currency":"USD","dateTimestamp":1769749200000,"payDate":"2026-02-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-26","recordDate":"2016-10-30","paymentDate":"2016-11-20","value":0.1,"currency":"USD"},{"executeDate":"2017-01-26","recordDate":"2017-01-30","paymentDate":"2017-02-20","value":0.14,"currency":"USD"},{"executeDate":"2017-04-26","recordDate":"2017-04-30","paymentDate":"2017-05-20","value":0.55,"currency":"USD"},{"executeDate":"2017-07-26","recordDate":"2017-07-30","paymentDate":"2017-08-20","value":0.16,"currency":"USD"},{"executeDate":"2017-10-27","recordDate":"2017-10-30","paymentDate":"2017-11-20","value":0.64,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MSB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MSB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MSB","date":"2026-08-21","current":26.378989,"percent":0.866558,"low":-38.747862,"twenty":4.365137,"median":8.519568,"eighty":23.996233,"high":62.374035,"avg":11.844551,"sd":15.757921,"marketCap":303728231},"quantilePoints":[{"date":"2021-08-27","current":14.321035,"twenty":7.92215,"median":9.862989,"eighty":19.442827,"marketCap":434928331},{"date":"2021-09-03","current":14.269194,"twenty":8.041009,"median":9.874955,"eighty":19.442827,"marketCap":433353930},{"date":"2021-09-10","current":13.975429,"twenty":8.103227,"median":9.884851,"eighty":19.442827,"marketCap":424432323},{"date":"2021-09-17","current":8.207495,"twenty":8.148799,"median":9.884851,"eighty":19.442827,"marketCap":414067515},{"date":"2021-09-24","current":7.666571,"twenty":8.148799,"median":9.884851,"eighty":19.442827,"marketCap":386777894},{"date":"2021-10-01","current":7.817405,"twenty":8.155204,"median":9.884851,"eighty":19.442827,"marketCap":394387500},{"date":"2021-10-08","current":8.909658,"twenty":8.178911,"median":9.884851,"eighty":19.442827,"marketCap":449491542},{"date":"2021-10-15","current":9.31015,"twenty":8.214989,"median":9.884851,"eighty":19.442827,"marketCap":469696358},{"date":"2021-10-22","current":8.00985,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":404096308},{"date":"2021-10-29","current":5.729123,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":289033820},{"date":"2021-11-05","current":5.796739,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":292445022},{"date":"2021-11-12","current":6.249243,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":315273840},{"date":"2021-11-19","current":6.36627,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":321177844},{"date":"2021-11-26","current":6.376673,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":321702645},{"date":"2021-12-03","current":5.960577,"twenty":8.296043,"median":9.884851,"eighty":19.442827,"marketCap":300710629},{"date":"2021-12-10","current":6.075003,"twenty":8.258056,"median":9.882451,"eighty":19.442827,"marketCap":306483433},{"date":"2021-12-17","current":5.332187,"twenty":8.205856,"median":9.868662,"eighty":19.442827,"marketCap":326950649},{"date":"2021-12-23","current":5.561137,"twenty":8.164698,"median":9.8408,"eighty":19.442827,"marketCap":340989059},{"date":"2021-12-31","current":5.653145,"twenty":8.117366,"median":9.813232,"eighty":19.442827,"marketCap":346630664},{"date":"2022-01-07","current":6.46196,"twenty":8.079042,"median":9.799052,"eighty":19.432897,"marketCap":396224302},{"date":"2022-01-14","current":6.84711,"twenty":7.994949,"median":9.778397,"eighty":19.432897,"marketCap":419840320},{"date":"2022-01-21","current":6.817154,"twenty":7.955658,"median":9.761872,"eighty":19.432897,"marketCap":418003518},{"date":"2022-01-28","current":6.660954,"twenty":7.897147,"median":9.748615,"eighty":19.422967,"marketCap":408425911},{"date":"2022-02-04","current":6.489776,"twenty":7.827807,"median":9.732651,"eighty":19.422967,"marketCap":397929903},{"date":"2022-02-11","current":4.745903,"twenty":7.776707,"median":9.712299,"eighty":19.422967,"marketCap":291001821},{"date":"2022-02-18","current":4.91922,"twenty":7.726264,"median":9.699393,"eighty":19.422967,"marketCap":301629029},{"date":"2022-02-25","current":5.531181,"twenty":7.711346,"median":9.689111,"eighty":19.422967,"marketCap":339152258},{"date":"2022-03-04","current":6.1517,"twenty":7.647338,"median":9.663255,"eighty":19.422967,"marketCap":377200287},{"date":"2022-03-11","current":5.732315,"twenty":7.603169,"median":9.643506,"eighty":19.422967,"marketCap":351485067},{"date":"2022-03-18","current":5.377121,"twenty":7.523215,"median":9.615182,"eighty":19.422967,"marketCap":329705851},{"date":"2022-03-25","current":5.576115,"twenty":7.433751,"median":9.563648,"eighty":19.422967,"marketCap":341907460},{"date":"2022-04-01","current":5.775109,"twenty":7.368615,"median":9.535937,"eighty":19.422967,"marketCap":354109069},{"date":"2022-04-08","current":5.77083,"twenty":7.332363,"median":9.509675,"eighty":19.422967,"marketCap":353846669},{"date":"2022-04-14","current":6.098207,"twenty":7.287197,"median":9.486402,"eighty":19.422967,"marketCap":373920285},{"date":"2022-04-22","current":5.84786,"twenty":7.226533,"median":9.464001,"eighty":19.422967,"marketCap":358569873},{"date":"2022-04-29","current":4.455012,"twenty":7.198978,"median":9.424368,"eighty":19.422967,"marketCap":306352233},{"date":"2022-05-06","current":4.453104,"twenty":7.152308,"median":9.393629,"eighty":19.422967,"marketCap":306221033},{"date":"2022-05-13","current":4.416854,"twenty":7.089761,"median":9.374172,"eighty":19.422967,"marketCap":303728231},{"date":"2022-05-20","current":4.912915,"twenty":7.078951,"median":9.353979,"eighty":19.422967,"marketCap":337840257},{"date":"2022-05-27","current":5.321212,"twenty":7.04177,"median":9.324975,"eighty":19.422967,"marketCap":365917078},{"date":"2022-06-03","current":5.517728,"twenty":7.011445,"median":9.303183,"eighty":19.422967,"marketCap":379430689},{"date":"2022-06-10","current":5.13805,"twenty":6.975788,"median":9.279949,"eighty":19.384666,"marketCap":353321869},{"date":"2022-06-17","current":4.470121,"twenty":6.908633,"median":9.226639,"eighty":18.927889,"marketCap":329837051},{"date":"2022-06-24","current":4.238969,"twenty":6.880108,"median":9.224675,"eighty":18.506575,"marketCap":312781038},{"date":"2022-07-01","current":4.447005,"twenty":6.851932,"median":9.199109,"eighty":17.713807,"marketCap":328131450},{"date":"2022-07-08","current":4.605255,"twenty":6.825712,"median":9.185421,"eighty":16.646163,"marketCap":339808259},{"date":"2022-07-15","current":4.763506,"twenty":6.809387,"median":9.135211,"eighty":16.2641,"marketCap":351485067},{"date":"2022-07-22","current":5.008882,"twenty":6.783832,"median":9.122367,"eighty":16.093709,"marketCap":369590681},{"date":"2022-07-29","current":4.848854,"twenty":6.770758,"median":9.087286,"eighty":15.962485,"marketCap":357782672},{"date":"2022-08-05","current":4.81507,"twenty":6.7312,"median":9.077185,"eighty":15.789928,"marketCap":355289870},{"date":"2022-08-12","current":4.912865,"twenty":6.702414,"median":9.056539,"eighty":15.672261,"marketCap":362505876},{"date":"2022-08-19","current":4.911087,"twenty":6.651769,"median":9.037159,"eighty":15.535838,"marketCap":362374676},{"date":"2022-08-26","current":4.887972,"twenty":6.607594,"median":8.99467,"eighty":15.506601,"marketCap":360669074},{"date":"2022-09-02","current":4.413222,"twenty":6.572859,"median":8.971791,"eighty":15.369203,"marketCap":325638648},{"date":"2022-09-09","current":4.382994,"twenty":6.528191,"median":8.964329,"eighty":15.299099,"marketCap":323408246},{"date":"2022-09-16","current":6.875197,"twenty":6.524127,"median":8.96128,"eighty":15.213561,"marketCap":289952221},{"date":"2022-09-23","current":6.411666,"twenty":6.511588,"median":8.939107,"eighty":15.092305,"marketCap":270403406},{"date":"2022-09-30","current":6.691651,"twenty":6.493183,"median":8.915544,"eighty":14.934585,"marketCap":282211415},{"date":"2022-10-07","current":6.579657,"twenty":6.493183,"median":8.906423,"eighty":14.852659,"marketCap":277488211},{"date":"2022-10-14","current":6.09746,"twenty":6.476584,"median":8.878367,"eighty":14.795244,"marketCap":257152196},{"date":"2022-10-21","current":5.885915,"twenty":6.448716,"median":8.865416,"eighty":14.728849,"marketCap":248230589},{"date":"2022-10-28","current":6.772536,"twenty":6.428184,"median":8.842366,"eighty":14.618912,"marketCap":285622617},{"date":"2022-11-04","current":6.844088,"twenty":6.428184,"median":8.824071,"eighty":14.541197,"marketCap":288640220},{"date":"2022-11-11","current":6.408555,"twenty":6.403577,"median":8.806467,"eighty":14.441489,"marketCap":270272206},{"date":"2022-11-18","current":6.511216,"twenty":6.385082,"median":8.800613,"eighty":14.30151,"marketCap":274601809},{"date":"2022-11-25","current":6.476996,"twenty":6.385082,"median":8.787482,"eighty":14.264298,"marketCap":273158608},{"date":"2022-12-02","current":5.898359,"twenty":6.328985,"median":8.774707,"eighty":14.213645,"marketCap":248755389},{"date":"2022-12-09","current":5.643261,"twenty":6.302262,"median":8.756991,"eighty":14.098055,"marketCap":237996981},{"date":"2022-12-16","current":9.216114,"twenty":6.297004,"median":8.756878,"eighty":13.970245,"marketCap":237472181},{"date":"2022-12-23","current":9.211023,"twenty":6.297004,"median":8.756878,"eighty":13.812658,"marketCap":237340980},{"date":"2022-12-30","current":9.17538,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":236422580},{"date":"2023-01-06","current":9.31795,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":240096183},{"date":"2023-01-13","current":10.081716,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":259776198},{"date":"2023-01-20","current":10.392315,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":267779404},{"date":"2023-01-27","current":12.159161,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":313305838},{"date":"2023-02-03","current":11.074613,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":285360217},{"date":"2023-02-10","current":11.344477,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":292313822},{"date":"2023-02-17","current":12.245721,"twenty":6.297004,"median":8.756878,"eighty":13.515598,"marketCap":315536240},{"date":"2023-02-24","current":13.834355,"twenty":6.297004,"median":8.756878,"eighty":13.630106,"marketCap":356470671},{"date":"2023-03-03","current":14.190779,"twenty":6.297004,"median":8.756878,"eighty":13.808351,"marketCap":365654678},{"date":"2023-03-10","current":12.917835,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":332854653},{"date":"2023-03-17","current":12.378107,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":318947443},{"date":"2023-03-24","current":11.970765,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":308451435},{"date":"2023-03-31","current":12.821092,"twenty":6.299242,"median":8.756934,"eighty":13.816142,"marketCap":330361851},{"date":"2023-04-06","current":12.64288,"twenty":6.299242,"median":8.756934,"eighty":13.816142,"marketCap":325769848},{"date":"2023-04-14","current":13.106231,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":337709057},{"date":"2023-04-21","current":13.080772,"twenty":6.297004,"median":8.756878,"eighty":13.818295,"marketCap":337053056},{"date":"2023-04-28","current":57.060874,"twenty":6.297004,"median":8.756878,"eighty":13.925928,"marketCap":302941030},{"date":"2023-05-05","current":51.994837,"twenty":6.297004,"median":8.756878,"eighty":13.980408,"marketCap":276045010},{"date":"2023-05-12","current":51.648864,"twenty":6.297004,"median":8.756878,"eighty":14.126967,"marketCap":274208209},{"date":"2023-05-19","current":46.953513,"twenty":6.297004,"median":8.756878,"eighty":14.213645,"marketCap":249280190},{"date":"2023-05-26","current":43.91389,"twenty":6.297004,"median":8.756878,"eighty":14.264298,"marketCap":233142577},{"date":"2023-06-02","current":45.446058,"twenty":6.297004,"median":8.756878,"eighty":14.30151,"marketCap":241276983},{"date":"2023-06-09","current":50.264971,"twenty":6.297004,"median":8.756878,"eighty":14.441489,"marketCap":266861003},{"date":"2023-06-16","current":-37.393042,"twenty":6.270379,"median":8.735647,"eighty":14.480013,"marketCap":271584207},{"date":"2023-06-23","current":-37.031757,"twenty":6.247683,"median":8.721221,"eighty":14.486061,"marketCap":268960205},{"date":"2023-06-30","current":-36.941435,"twenty":6.218808,"median":8.716855,"eighty":14.492109,"marketCap":268304204},{"date":"2023-07-07","current":-35.496294,"twenty":6.210234,"median":8.705156,"eighty":14.492109,"marketCap":257808196},{"date":"2023-07-14","current":-35.189201,"twenty":6.181218,"median":8.685564,"eighty":14.492109,"marketCap":255577794},{"date":"2023-07-21","current":-32.60601,"twenty":6.154061,"median":8.674365,"eighty":14.492109,"marketCap":236816180},{"date":"2023-07-28","current":-33.129874,"twenty":6.097609,"median":8.661292,"eighty":14.492109,"marketCap":240620983},{"date":"2023-08-04","current":-33.039553,"twenty":6.075523,"median":8.653322,"eighty":14.492109,"marketCap":239964982},{"date":"2023-08-11","current":-33.382774,"twenty":6.020032,"median":8.643963,"eighty":14.492109,"marketCap":242457784},{"date":"2023-08-18","current":-35.171137,"twenty":5.987797,"median":8.629945,"eighty":14.492109,"marketCap":255446594},{"date":"2023-08-25","current":-34.520823,"twenty":5.943601,"median":8.624946,"eighty":14.492109,"marketCap":250723391},{"date":"2023-09-01","current":-33.292452,"twenty":5.909129,"median":8.610547,"eighty":14.492109,"marketCap":241801784},{"date":"2023-09-08","current":-35.514358,"twenty":5.894041,"median":8.601908,"eighty":14.492109,"marketCap":257939396},{"date":"2023-09-15","current":39.702173,"twenty":5.872677,"median":8.585815,"eighty":14.527756,"marketCap":269091405},{"date":"2023-09-22","current":38.42458,"twenty":5.872677,"median":8.585815,"eighty":14.60041,"marketCap":260432198},{"date":"2023-09-29","current":39.469884,"twenty":5.872677,"median":8.585815,"eighty":14.726257,"marketCap":267517003},{"date":"2023-10-06","current":38.889159,"twenty":5.872677,"median":8.585815,"eighty":14.790701,"marketCap":263581000},{"date":"2023-10-13","current":39.489241,"twenty":5.872677,"median":8.585815,"eighty":14.849843,"marketCap":267648204},{"date":"2023-10-20","current":41.173341,"twenty":5.872677,"median":8.585815,"eighty":14.911002,"marketCap":279062612},{"date":"2023-10-27","current":39.973178,"twenty":5.862589,"median":8.583863,"eighty":14.969045,"marketCap":270928206},{"date":"2023-11-03","current":39.450526,"twenty":5.862589,"median":8.583863,"eighty":15.136664,"marketCap":267385803},{"date":"2023-11-10","current":36.81791,"twenty":5.862589,"median":8.583863,"eighty":15.287127,"marketCap":249542590},{"date":"2023-11-17","current":36.604978,"twenty":5.862589,"median":8.583863,"eighty":15.318107,"marketCap":248099389},{"date":"2023-11-24","current":37.805141,"twenty":5.862589,"median":8.583863,"eighty":15.431138,"marketCap":256233795},{"date":"2023-12-01","current":34.746661,"twenty":5.862589,"median":8.586662,"eighty":15.515483,"marketCap":235504179},{"date":"2023-12-08","current":35.753249,"twenty":5.866073,"median":8.601908,"eighty":15.571263,"marketCap":242326584},{"date":"2023-12-15","current":23.302471,"twenty":5.866073,"median":8.622066,"eighty":15.716949,"marketCap":262793800},{"date":"2023-12-22","current":23.965596,"twenty":5.866073,"median":8.629106,"eighty":15.869403,"marketCap":270272206},{"date":"2023-12-29","current":23.442076,"twenty":5.862589,"median":8.635662,"eighty":15.962485,"marketCap":264368201},{"date":"2024-01-05","current":22.965091,"twenty":5.859106,"median":8.645105,"eighty":16.033222,"marketCap":258988997},{"date":"2024-01-12","current":23.45371,"twenty":5.859106,"median":8.653322,"eighty":16.214685,"marketCap":264499401},{"date":"2024-01-19","current":24.396046,"twenty":5.855622,"median":8.653322,"eighty":16.42527,"marketCap":275126609},{"date":"2024-01-26","current":24.291342,"twenty":5.859106,"median":8.653322,"eighty":17.232219,"marketCap":273945808},{"date":"2024-02-02","current":22.93019,"twenty":5.859106,"median":8.671616,"eighty":18.310814,"marketCap":258595397},{"date":"2024-02-09","current":21.522502,"twenty":5.859106,"median":8.679621,"eighty":18.769009,"marketCap":242720185},{"date":"2024-02-16","current":22.046022,"twenty":5.859106,"median":8.680764,"eighty":19.363387,"marketCap":248624189},{"date":"2024-02-23","current":20.929179,"twenty":5.859106,"median":8.680764,"eighty":19.442827,"marketCap":236028979},{"date":"2024-03-01","current":20.254419,"twenty":5.862589,"median":8.683164,"eighty":19.631496,"marketCap":228419374},{"date":"2024-03-08","current":21.429431,"twenty":5.862589,"median":8.683164,"eighty":19.678308,"marketCap":241670584},{"date":"2024-03-15","current":20.207884,"twenty":5.862589,"median":8.704624,"eighty":19.825839,"marketCap":227894573},{"date":"2024-03-22","current":22.290331,"twenty":5.862589,"median":8.712805,"eighty":19.906697,"marketCap":251379391},{"date":"2024-03-28","current":20.615066,"twenty":5.862589,"median":8.717064,"eighty":19.947775,"marketCap":232486577},{"date":"2024-04-05","current":20.766306,"twenty":5.859106,"median":8.713303,"eighty":20.0096,"marketCap":234192178},{"date":"2024-04-12","current":20.254419,"twenty":5.859106,"median":8.713303,"eighty":20.055646,"marketCap":228419374},{"date":"2024-04-19","current":19.85887,"twenty":5.859106,"median":8.713303,"eighty":20.074831,"marketCap":223958570},{"date":"2024-04-26","current":11.928956,"twenty":5.862589,"median":8.721024,"eighty":20.117816,"marketCap":226451372},{"date":"2024-05-03","current":11.645591,"twenty":5.862589,"median":8.747115,"eighty":20.117816,"marketCap":221072168},{"date":"2024-05-10","current":11.528098,"twenty":5.862589,"median":8.779066,"eighty":20.117816,"marketCap":218841766},{"date":"2024-05-17","current":12.215776,"twenty":5.862589,"median":8.887537,"eighty":20.117816,"marketCap":231896176},{"date":"2024-05-24","current":11.94969,"twenty":5.862589,"median":9.049567,"eighty":20.117816,"marketCap":226844972},{"date":"2024-05-31","current":11.859842,"twenty":5.862589,"median":9.063156,"eighty":20.117816,"marketCap":225139371},{"date":"2024-06-07","current":12.184675,"twenty":5.862589,"median":9.102665,"eighty":20.117816,"marketCap":231305776},{"date":"2024-06-14","current":10.309287,"twenty":5.859106,"median":9.17538,"eighty":20.119317,"marketCap":221072168},{"date":"2024-06-21","current":10.645792,"twenty":5.855622,"median":9.200439,"eighty":20.120818,"marketCap":228288174},{"date":"2024-06-28","current":10.700856,"twenty":5.850427,"median":9.211511,"eighty":20.133396,"marketCap":229468974},{"date":"2024-07-05","current":10.817104,"twenty":5.850427,"median":9.246665,"eighty":20.133396,"marketCap":231961776},{"date":"2024-07-12","current":10.572373,"twenty":5.850427,"median":9.31015,"eighty":20.133396,"marketCap":226713772},{"date":"2024-07-15","current":10.676383,"twenty":5.850427,"median":9.31015,"eighty":20.133396,"marketCap":228944174},{"date":"2024-08-02","current":10.639674,"twenty":5.828602,"median":9.379742,"eighty":20.19625,"marketCap":228156973},{"date":"2024-08-09","current":10.05232,"twenty":5.828602,"median":9.526988,"eighty":20.19625,"marketCap":215561764},{"date":"2024-08-16","current":10.284814,"twenty":5.828602,"median":9.589821,"eighty":20.19625,"marketCap":220547368},{"date":"2024-08-23","current":10.86605,"twenty":5.828602,"median":9.656301,"eighty":20.19625,"marketCap":233011377},{"date":"2024-08-30","current":10.419416,"twenty":5.828602,"median":9.675118,"eighty":20.19625,"marketCap":223433770},{"date":"2024-09-06","current":10.609082,"twenty":5.828602,"median":9.698882,"eighty":20.19625,"marketCap":227500973},{"date":"2024-09-13","current":15.335191,"twenty":5.828602,"median":9.716249,"eighty":20.19625,"marketCap":270797006},{"date":"2024-09-20","current":16.159903,"twenty":5.828602,"median":9.747943,"eighty":20.19625,"marketCap":285360217},{"date":"2024-09-27","current":17.920775,"twenty":5.828602,"median":9.762249,"eighty":20.19625,"marketCap":316454641},{"date":"2024-10-04","current":17.110923,"twenty":5.828602,"median":9.791031,"eighty":20.19625,"marketCap":302153830},{"date":"2024-10-11","current":18.017363,"twenty":5.828602,"median":9.831688,"eighty":20.19625,"marketCap":318160242},{"date":"2024-10-18","current":19.10955,"twenty":5.828602,"median":9.892565,"eighty":20.19625,"marketCap":337446657},{"date":"2024-10-25","current":18.478013,"twenty":5.828602,"median":10.067018,"eighty":20.19625,"marketCap":326294648},{"date":"2024-10-31","current":17.70531,"twenty":5.828602,"median":10.247199,"eighty":20.19625,"marketCap":312649838},{"date":"2024-11-08","current":19.488472,"twenty":5.825777,"median":10.328667,"eighty":20.198577,"marketCap":344137862},{"date":"2024-11-15","current":19.176419,"twenty":5.825777,"median":10.40718,"eighty":20.198577,"marketCap":338627458},{"date":"2024-11-22","current":19.718797,"twenty":5.825777,"median":10.509425,"eighty":20.198577,"marketCap":348205065},{"date":"2024-11-29","current":20.625237,"twenty":5.825777,"median":10.554018,"eighty":20.208641,"marketCap":364211477},{"date":"2024-12-06","current":19.949122,"twenty":5.825777,"median":10.578491,"eighty":20.254419,"marketCap":352272268},{"date":"2024-12-13","current":19.55534,"twenty":5.825777,"median":10.645792,"eighty":20.254419,"marketCap":345318663},{"date":"2024-12-20","current":4.190214,"twenty":5.776821,"median":10.645792,"eighty":20.254419,"marketCap":385072293},{"date":"2024-12-27","current":4.083139,"twenty":5.768943,"median":10.645792,"eighty":20.254419,"marketCap":375232286},{"date":"2025-01-03","current":4.038881,"twenty":5.731677,"median":10.645792,"eighty":20.254419,"marketCap":371165082},{"date":"2025-01-10","current":3.816165,"twenty":5.713799,"median":10.658029,"eighty":20.254419,"marketCap":350697867},{"date":"2025-01-17","current":4.095988,"twenty":5.678286,"median":10.658029,"eighty":20.254419,"marketCap":376413086},{"date":"2025-01-24","current":4.442912,"twenty":5.654429,"median":10.658029,"eighty":20.254419,"marketCap":408294711},{"date":"2025-01-31","current":3.600586,"twenty":5.616769,"median":10.658029,"eighty":20.254419,"marketCap":330886652},{"date":"2025-02-07","current":3.570605,"twenty":5.596228,"median":10.658029,"eighty":20.254419,"marketCap":328131450},{"date":"2025-02-14","current":3.589165,"twenty":5.561137,"median":10.658029,"eighty":20.254419,"marketCap":329837051},{"date":"2025-02-21","current":4.63422,"twenty":5.552578,"median":10.658029,"eighty":20.254419,"marketCap":425875524},{"date":"2025-02-28","current":4.061724,"twenty":5.531426,"median":10.658029,"eighty":20.254419,"marketCap":373264284},{"date":"2025-03-07","current":3.562039,"twenty":5.493094,"median":10.670265,"eighty":20.254419,"marketCap":327344249},{"date":"2025-03-14","current":3.661976,"twenty":5.442781,"median":10.670265,"eighty":20.254419,"marketCap":336528256},{"date":"2025-03-21","current":3.998906,"twenty":5.442781,"median":10.670265,"eighty":20.254419,"marketCap":367491480},{"date":"2025-03-28","current":3.856139,"twenty":5.405365,"median":10.670265,"eighty":20.254419,"marketCap":354371470},{"date":"2025-04-04","current":3.673397,"twenty":5.360747,"median":10.670265,"eighty":20.254419,"marketCap":337577857},{"date":"2025-04-11","current":3.643416,"twenty":5.327797,"median":10.658029,"eighty":20.254419,"marketCap":334822655},{"date":"2025-04-17","current":3.80046,"twenty":5.306926,"median":10.658029,"eighty":20.254419,"marketCap":349254666},{"date":"2025-04-25","current":3.856913,"twenty":5.195406,"median":10.670265,"eighty":20.254419,"marketCap":359750674},{"date":"2025-05-02","current":3.840034,"twenty":5.123168,"median":10.670265,"eighty":20.254419,"marketCap":358176273},{"date":"2025-05-09","current":3.885045,"twenty":5.078195,"median":10.670265,"eighty":20.254419,"marketCap":362374676},{"date":"2025-05-16","current":3.575592,"twenty":5.017061,"median":10.670265,"eighty":20.254419,"marketCap":333510654},{"date":"2025-05-23","current":3.585438,"twenty":4.981646,"median":10.670265,"eighty":20.254419,"marketCap":334429054},{"date":"2025-05-30","current":3.56012,"twenty":4.947731,"median":10.670265,"eighty":20.254419,"marketCap":332067453},{"date":"2025-06-06","current":3.683901,"twenty":4.911798,"median":10.670265,"eighty":20.254419,"marketCap":343613061},{"date":"2025-06-13","current":3.741285,"twenty":4.855542,"median":10.670265,"eighty":20.254419,"marketCap":349517066},{"date":"2025-06-20","current":3.370527,"twenty":4.827873,"median":10.670265,"eighty":20.254419,"marketCap":314880240},{"date":"2025-06-27","current":3.311543,"twenty":4.761406,"median":10.670265,"eighty":20.254419,"marketCap":309369835},{"date":"2025-07-03","current":3.510966,"twenty":4.740135,"median":10.670265,"eighty":20.254419,"marketCap":328000250},{"date":"2025-07-11","current":3.473047,"twenty":4.726695,"median":10.670265,"eighty":20.254419,"marketCap":324457847},{"date":"2025-07-18","current":3.613486,"twenty":4.69441,"median":10.670265,"eighty":20.254419,"marketCap":337577857},{"date":"2025-07-25","current":3.982839,"twenty":4.619882,"median":10.670265,"eighty":20.254419,"marketCap":372083483},{"date":"2025-08-01","current":4.109234,"twenty":4.59921,"median":10.670265,"eighty":20.254419,"marketCap":383891492},{"date":"2025-08-08","current":4.062889,"twenty":4.498513,"median":10.670265,"eighty":20.254419,"marketCap":379561889},{"date":"2025-08-15","current":4.364832,"twenty":4.453486,"median":10.670265,"eighty":20.254419,"marketCap":407769910},{"date":"2025-08-22","current":4.548807,"twenty":4.453486,"median":10.670265,"eighty":20.254419,"marketCap":424957123},{"date":"2025-08-29","current":4.367641,"twenty":4.443375,"median":10.670265,"eighty":20.254419,"marketCap":408032311},{"date":"2025-09-05","current":4.41539,"twenty":4.425668,"median":10.670265,"eighty":20.254419,"marketCap":412493114},{"date":"2025-09-12","current":4.487014,"twenty":4.415683,"median":10.61629,"eighty":20.254419,"marketCap":419184319},{"date":"2025-09-19","current":4.302261,"twenty":4.401679,"median":10.572373,"eighty":20.254419,"marketCap":399110704},{"date":"2025-09-26","current":4.150933,"twenty":4.38646,"median":10.535663,"eighty":20.254419,"marketCap":385072293},{"date":"2025-10-03","current":4.555419,"twenty":4.379438,"median":10.419416,"eighty":20.254419,"marketCap":422595522},{"date":"2025-10-10","current":4.389947,"twenty":4.374156,"median":10.349056,"eighty":20.254419,"marketCap":407245110},{"date":"2025-10-17","current":4.340447,"twenty":4.367859,"median":10.278696,"eighty":20.254419,"marketCap":402653106},{"date":"2025-10-24","current":5.057491,"twenty":4.367859,"median":10.104629,"eighty":20.254419,"marketCap":469171557},{"date":"2025-10-31","current":4.937276,"twenty":4.367859,"median":9.689649,"eighty":20.254419,"marketCap":458019549},{"date":"2025-11-07","current":4.843933,"twenty":4.367859,"median":9.532858,"eighty":20.254419,"marketCap":449360342},{"date":"2025-11-14","current":4.82979,"twenty":4.367859,"median":9.324452,"eighty":20.254419,"marketCap":448048341},{"date":"2025-11-21","current":4.747762,"twenty":4.367859,"median":9.246665,"eighty":20.254419,"marketCap":440438735},{"date":"2025-11-28","current":4.518647,"twenty":4.365351,"median":9.205931,"eighty":20.254419,"marketCap":419184319},{"date":"2025-12-05","current":4.747762,"twenty":4.365351,"median":9.129554,"eighty":20.254419,"marketCap":440438735},{"date":"2025-12-12","current":4.995262,"twenty":4.365351,"median":8.723715,"eighty":20.254419,"marketCap":463398753},{"date":"2025-12-19","current":26.614198,"twenty":4.365351,"median":8.723715,"eighty":20.282617,"marketCap":458019549},{"date":"2025-12-26","current":27.460425,"twenty":4.365351,"median":8.723715,"eighty":20.302476,"marketCap":472582760},{"date":"2026-01-02","current":29.36634,"twenty":4.365351,"median":8.723715,"eighty":20.36843,"marketCap":505382785},{"date":"2026-01-09","current":31.371362,"twenty":4.365351,"median":8.723715,"eighty":20.404151,"marketCap":539888411},{"date":"2026-01-16","current":30.982556,"twenty":4.365351,"median":8.723715,"eighty":20.506673,"marketCap":533197206},{"date":"2026-01-23","current":27.841608,"twenty":4.365351,"median":8.723715,"eighty":20.582715,"marketCap":479142765},{"date":"2026-01-30","current":25.63837,"twenty":4.365351,"median":8.723715,"eighty":20.623235,"marketCap":441225936},{"date":"2026-02-06","current":26.26351,"twenty":4.365351,"median":8.723715,"eighty":20.696503,"marketCap":451984344},{"date":"2026-02-13","current":25.943316,"twenty":4.365351,"median":8.723715,"eighty":20.763979,"marketCap":446473940},{"date":"2026-02-20","current":25.188574,"twenty":4.365351,"median":8.723715,"eighty":20.867453,"marketCap":433485130},{"date":"2026-02-27","current":23.671465,"twenty":4.365351,"median":8.723715,"eighty":20.922568,"marketCap":407376310},{"date":"2026-03-06","current":23.183551,"twenty":4.365351,"median":8.723715,"eighty":20.982694,"marketCap":398979504},{"date":"2026-03-13","current":24.38809,"twenty":4.365351,"median":8.723715,"eighty":21.023964,"marketCap":419709119},{"date":"2026-03-20","current":23.053949,"twenty":4.365351,"median":8.723715,"eighty":21.091972,"marketCap":396749102},{"date":"2026-03-27","current":23.465627,"twenty":4.365351,"median":8.723715,"eighty":21.254925,"marketCap":403833907},{"date":"2026-04-02","current":24.822638,"twenty":4.365351,"median":8.723715,"eighty":21.274377,"marketCap":427187525},{"date":"2026-04-10","current":23.488498,"twenty":4.365351,"median":8.723715,"eighty":21.274377,"marketCap":404227508},{"date":"2026-04-17","current":23.488498,"twenty":4.365351,"median":8.723715,"eighty":21.274377,"marketCap":404227508},{"date":"2026-04-24","current":26.072069,"twenty":4.365351,"median":8.723715,"eighty":21.274377,"marketCap":361587475},{"date":"2026-05-01","current":26.289651,"twenty":4.365351,"median":8.723715,"eighty":21.413122,"marketCap":364605077},{"date":"2026-05-08","current":27.150522,"twenty":4.365351,"median":8.723715,"eighty":21.472794,"marketCap":376544287},{"date":"2026-05-15","current":27.04646,"twenty":4.365351,"median":8.723715,"eighty":21.666727,"marketCap":375101085},{"date":"2026-05-22","current":24.681432,"twenty":4.365351,"median":8.723715,"eighty":21.805193,"marketCap":342301060},{"date":"2026-05-29","current":25.050377,"twenty":4.365213,"median":8.537772,"eighty":21.964585,"marketCap":347417864},{"date":"2026-06-05","current":24.44493,"twenty":4.365351,"median":8.723715,"eighty":22.405157,"marketCap":339021058},{"date":"2026-06-12","current":23.357017,"twenty":4.365351,"median":8.723715,"eighty":22.740759,"marketCap":323933046},{"date":"2026-06-18","current":28.638056,"twenty":4.365351,"median":8.723715,"eighty":22.916229,"marketCap":324326647},{"date":"2026-06-26","current":28.209412,"twenty":4.365213,"median":8.537772,"eighty":23.069795,"marketCap":319472243},{"date":"2026-07-02","current":29.831309,"twenty":4.365213,"median":8.537772,"eighty":23.120514,"marketCap":337840257},{"date":"2026-07-10","current":29.34474,"twenty":4.365213,"median":8.537772,"eighty":23.183551,"marketCap":332329853},{"date":"2026-07-17","current":28.487452,"twenty":4.365213,"median":8.537772,"eighty":23.357017,"marketCap":322621045},{"date":"2026-07-24","current":26.378986,"twenty":4.365213,"median":8.537772,"eighty":23.465627,"marketCap":298742627},{"date":"2026-07-31","current":26.622271,"twenty":4.365137,"median":8.519568,"eighty":23.627248,"marketCap":301497829},{"date":"2026-08-07","current":26.668611,"twenty":4.365137,"median":8.519568,"eighty":23.76625,"marketCap":302022630},{"date":"2026-08-14","current":26.96982,"twenty":4.365137,"median":8.519568,"eighty":23.884928,"marketCap":305433832},{"date":"2026-08-21","current":26.819215,"twenty":4.365137,"median":8.519568,"eighty":23.996233,"marketCap":303728231}],"updateTime":1787507013369},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640671409","title":"The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2640671409","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640671409?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:30","pubTimestamp":1780349408,"startTime":"0","endTime":"0","summary":"London, UK, June 1st, 2026, FinanceWire 1% Royalty Acquisition on One of the United States’ Only Large-Scale Sources of Merchant DR-Grade Iro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/the-metals-royalty-company-inc-closes-mesabi-royalty-acquisition-exercises-option-to-acquire-an-additional-1-royalty-interest-and-appoints-michael-hess-as-non-executive-co-chairman?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/the-metals-royalty-company-inc-closes-mesabi-royalty-acquisition-exercises-option-to-acquire-an-additional-1-royalty-interest-and-appoints-michael-hess-as-non-executive-co-chairman?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4006","LU0456854461.SGD","BK4535","LU0368265418.SGD","MSB","IE0002270589.USD","LU0266512127.USD","LU0300736062.USD","IE00B19Z3581.USD","BK4585","LU0122376428.USD","IE00B19Z3B42.SGD","HES","PICK","LU0788109394.HKD","IE00B7SZLL34.SGD","LU0300736492.USD","LU1169589451.USD","BK4588","LU1169590202.USD","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640626979","title":"The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2640626979","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640626979?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:42","pubTimestamp":1780346579,"startTime":"0","endTime":"0","summary":"The Metals Royalty Company  said late Monday it closed the acquisition of a 1.0% index-priced gross overriding production royalty with a revenue floor in the Mesabi Metallics iron ore project located in Nashwauk, Minnesota.The acquisition of the initial royalty was funded concurrently with proceeds from an upsized $80.1 million private placement at $13.00 per share, and a net $43 million draw under its senior secured acquisition credit facility entered into on June 1, the company said.An additional $7 million delayed draw will be accessible when it completes the acquisition of the additional 1.0% royalty, the company added.The company said it has exercised the option to buy an additional 1.0% royalty on the same terms as the initial royalty, provided the closing conditions including raising the necessary funding, are satisfied before July 31.Mesabi Metallics is targeting commissioning of operations in the second half of 2026, the company said.Metals Royalty added that it has appointed ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TMCR","LU1169590202.USD","LU0266512127.USD","IE00B19Z3B42.SGD","BK4585","BK4588","BK4168","IE0002270589.USD","HES","MSB","LU0300736062.USD","LU0368265418.SGD","LU0456854461.SGD","PICK","IE00B19Z3581.USD","BK4006","LU0788109394.HKD","LU1169589451.USD","BK4535","BK4213","LU0122376428.USD","IE00B7SZLL34.SGD","LU0300736492.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633972051","title":"Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L","url":"https://stock-news.laohu8.com/highlight/detail?id=2633972051","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633972051?lang=en_us&edition=fundamental","pubTime":"2026-05-07 11:57","pubTimestamp":1778126267,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) has reached full patient recruitment for its pivotal Phase 3 trial of rexlemestrocel-L in chronic low back pain, a key step toward confirmatory data supporting a potential US regulatory filing.\nSee our latest analysis for Mesoblast.\nDespite the latest clinical milestone, Mesoblast’s 1 day share price return of a 4.13% decline and 7 day share price return of a 5.86% decline show some cooling momentum. However, the 3 year total shareholder return of 102.23% reflects a strong...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/assessing-mesoblast-asxmsb-valuation-after-phase-3-recruitme","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/assessing-mesoblast-asxmsb-valuation-after-phase-3-recruitme","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4006","BK7067","BK7508","MSB.AU","BK7501","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633625909","title":"Mesabi Trust Reports Higher Shipments But No Bonus Royalties","url":"https://stock-news.laohu8.com/highlight/detail?id=2633625909","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633625909?lang=en_us&edition=fundamental","pubTime":"2026-05-05 06:37","pubTimestamp":1777934254,"startTime":"0","endTime":"0","summary":"Mesabi Shs ( ($MSB) ) just unveiled an update. Mesabi Trust reported that, according to a quarterly royalty report from Cleveland-Cliffs, it receiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesabi-trust-reports-higher-shipments-but-no-bonus-royalties?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesabi-trust-reports-higher-shipments-but-no-bonus-royalties?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4006","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632227266","title":"Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632227266","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632227266?lang=en_us&edition=fundamental","pubTime":"2026-05-02 11:34","pubTimestamp":1777692888,"startTime":"0","endTime":"0","summary":"In late April 2026, Mesoblast Limited reported it had completed patient recruitment for its pivotal 300-patient Phase 3 trial of rexlemestrocel-L in chronic low back pain due to degenerative disc disease, a placebo-controlled study designed around a 12-month pain reduction endpoint and supported by the therapy’s RMAT designation.\nThis milestone moves rexlemestrocel-L closer to potential FDA submission for a condition affecting over 7 million Americans and heavily tied to opioid use,...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-completing-phase-3-enrollment-for-rexlemestrocel-l-reshap","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-completing-phase-3-enrollment-for-rexlemestrocel-l-reshap","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7508","BK7067","BK4006","MSB.AU","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555111","title":"Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555111","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631555111?lang=en_us&edition=fundamental","pubTime":"2026-04-29 08:53","pubTimestamp":1777423980,"startTime":"0","endTime":"0","summary":"NEW YORK, April  28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/29/3283366/0/en/Mesoblast-Achieves-Patient-Recruitment-Target-in-Pivotal-Phase-3-Trial-for-Chronic-Low-Back-Pain.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK4161","BK4546","BK4585","MESO","BK4575","BK4551","BK4139","DDD","BK4588","BK4150","BK4170","MSC","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629750895","title":"Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2629750895","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629750895?lang=en_us&edition=fundamental","pubTime":"2026-04-24 10:19","pubTimestamp":1776997156,"startTime":"0","endTime":"0","summary":"Mesabi Trust (MSB) has put fresh FY 2026 numbers on the table, with third quarter revenue of US$3.6 million, basic EPS of US$0.21 and net income of US$2.8 million. The trust has seen quarterly revenue move between US$4.7 million and US$6.9 million and EPS range from US$0.28 to US$0.46 over the past year of reported periods, alongside net income between US$3.6 million and US$6.1 million. This sets a clear context for the latest print. With a trailing net margin of 82.8% and earnings quality...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2055000-choice2-main-header/1585186660639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-msb/mesabi-trust/news/mesabi-trust-msb-q3-net-margin-strengthens-bearish-dividend","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-msb/mesabi-trust/news/mesabi-trust-msb-q3-net-margin-strengthens-bearish-dividend","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4006","MSB","BK7067","BK7508","MSB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629078725","title":"Mesabi Trust publishes fiscal 2026 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2629078725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629078725?lang=en_us&edition=fundamental","pubTime":"2026-04-23 04:41","pubTimestamp":1776890470,"startTime":"0","endTime":"0","summary":"Mesabi Trust filed its annual report for fiscal year ended Jan. 31, 2026, highlighting weaker royalty-driven performance tied to lower pellet shipments and pricing at Northshore.Pellet production and shipments from Mesabi Trust lands fell to 3,493,854 tons from 3,862,061 tons.Trust reported reduced bonus royalty generation late in year as limited third-party pellet sales were priced below 2026 adjusted threshold price of USD 71.7 per ton.Mesabi Trust maintained a cash reserve to manage volatile royalties, with unallocated reserve declining to USD 20.4 million from USD 23.3 million.Arbitration against Northshore and Cleveland-Cliffs remained active, targeting damages tied to 2022–2023 idling and alleged underpayment on intercompany shipments since 2023.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and shou","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL47BGhb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CLF","BK4006","BK4585","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628762489","title":"Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil","url":"https://stock-news.laohu8.com/highlight/detail?id=2628762489","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628762489?lang=en_us&edition=fundamental","pubTime":"2026-04-19 21:04","pubTimestamp":1776603864,"startTime":"0","endTime":"0","summary":"On 8 April 2026, Mesoblast Limited announced that the FDA granted Investigational New Drug clearance to proceed directly to a registrational trial of Ryoncil (remestemcel‑L‑rknd) in 76 children with Duchenne muscular dystrophy, using time‑to‑stand at nine months as the primary endpoint.\nThis marks an expansion of Ryoncil’s use beyond steroid‑refractory acute graft‑versus‑host disease into another rare pediatric indication, leveraging its existing FDA‑approved manufacturing platform and...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-61-after-fda-clears-registrational-dm","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-is-up-61-after-fda-clears-registrational-dm","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MSB","BK7067","BK4585","BK7508","MSB.AU","BK4588","BK7501","LABU","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628109572","title":"Mesoblast (ASX:MSB) Valuation Check As New CAR Technology License Targets Stronger Cell Therapy Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2628109572","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628109572?lang=en_us&edition=fundamental","pubTime":"2026-04-16 22:08","pubTimestamp":1776348536,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) recently secured an exclusive worldwide license to a patented chimeric antigen receptor technology from Mayo Clinic, with the goal of refining the targeting and immune effects of its mesenchymal stromal cell therapies.\nSee our latest analysis for Mesoblast.\nAt a share price of A$2.24, Mesoblast has seen a 10.89% 1 month share price return and a 10.34% 7 day share price return. Over 90 days, the share price return is a 15.15% decline, while the 3 year total shareholder...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-new-car-technology-licen","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-new-car-technology-licen","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","MSB.AU","BK4230","BK7501","BK4006","CAR","BK4022","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627550421","title":"Press Release: Mesabi Trust Press Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2627550421","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627550421?lang=en_us&edition=fundamental","pubTime":"2026-04-15 04:05","pubTimestamp":1776197100,"startTime":"0","endTime":"0","summary":"The Trustees of Mesabi Trust  declared a distribution of twenty-four cents  per Unit of Beneficial Interest payable on May 20, 2026 to Mesabi Trust Unitholders of record at the close of business on April 30, 2026. This compares to a fifty-six cents  per Unit distribution declared for the same period last year.This press release contains certain forward-looking statements with respect to Northshore operations and Cliffs during 2026 and other matters, which statements are intended to be made under the safe harbor protections of the Private Securities Litigation Reform Act of 1995, as amended. Actual production, prices, price adjustments, sales, shipments and deemed shipments of iron ore pellets, as w","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626889120","title":"Did FDA-Cleared Duchenne Trial for Ryoncil Just Shift Mesoblast's (ASX:MSB) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2626889120","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626889120?lang=en_us&edition=fundamental","pubTime":"2026-04-12 04:28","pubTimestamp":1775939339,"startTime":"0","endTime":"0","summary":"Earlier this week, Mesoblast Limited announced that the FDA granted Investigational New Drug clearance to proceed directly to a registrational trial of Ryoncil (remestemcel-L-rknd) in 76 children with Duchenne muscular dystrophy, using time-to-stand at nine months as the primary approval endpoint.\nThis move extends the use of the first FDA-approved mesenchymal stromal cell therapy beyond steroid‑refractory pediatric graft-versus-host disease and leverages a partnership with Parent Project...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/did-fda-cleared-duchenne-trial-for-ryoncil-just-shift-mesobl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/did-fda-cleared-duchenne-trial-for-ryoncil-just-shift-mesobl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK7508","MSB.AU","BK4585","BK7501","BK4006","BK4588","MSB","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626110779","title":"Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION","url":"https://stock-news.laohu8.com/highlight/detail?id=2626110779","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626110779?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:09","pubTimestamp":1775851740,"startTime":"0","endTime":"0","summary":"Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness efforts ~15,000 children are living with DMD in the U.S. NEW YORK, April  10, 202","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/10/3272039/0/en/Mesoblast-Receives-IND-Clearance-From-FDA-to-Directly-Proceed-to-Registrational-Trial-for-Approval-of-Ryoncil-in-Duchenne-Muscular-Dystrophy-CORRECTION.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4006","BK4575","BK4585","BK4588","IND","MESO","BK4150","MSB","BK4139","MSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625947672","title":"Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2625947672","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625947672?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:07","pubTimestamp":1775653620,"startTime":"0","endTime":"0","summary":"Mesoblast outlines commercial strategy to double net revenues as Ryoncil approaches US$100M net revenue milestone since launch last year  Showcases transformative blockbuster products for inflammatory","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3270209/0/en/Mesoblast-R-D-Day-Features-Significant-Commercial-Progress-Platform-Innovation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","MESO","PRGS","BK4575","MSB","BK4139","MSC","LU2065732104.USD","BK4150","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949485","title":"Is Mesoblast (ASX:MSB) Offering Value After Recent Share Price Declines?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949485","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949485?lang=en_us&edition=fundamental","pubTime":"2026-04-08 16:35","pubTimestamp":1775637306,"startTime":"0","endTime":"0","summary":"Wondering if Mesoblast at around A$2.02 is giving you genuine value or just fresh volatility? This article walks through what the numbers are actually saying about the stock.\nThe share price has had a mixed run, with a 7 day return of an 11.0% decline and a 30 day return of a 4.3% decline, set against a year to date return of a 27.1% decline, a 1 year return of 25.9%, and a 3 year return of 112.0%.\nThese moves sit alongside ongoing attention on Mesoblast's position in the biotech sector and...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-offering-value-after-recent-share-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/is-mesoblast-asxmsb-offering-value-after-recent-share-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","DCF","MSB","MSB.AU","BK7508","BK7067","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625986886","title":"Macquarie Group Rise After Financing Mesabi's Minnesota Iron Ore Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2625986886","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625986886?lang=en_us&edition=fundamental","pubTime":"2026-04-07 10:24","pubTimestamp":1775528671,"startTime":"0","endTime":"0","summary":"Shares of Macquarie Group  rose around 3% in recent Tuesday trade after Mesabi Metallics said on Monday that it had secured $150 million in financing from the bank to support the third-quarter startup of its world-scale iron ore mine and pellet plant in Minnesota.The $2.5 billion project, spanning over 16,000 acres, aims to supply DR-grade iron ore for next-generation electric arc furnaces, representing one of Minnesota's largest private-sector industrial investments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MQG.AU","BK4006","MSB","BK7511","BK7046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625983628","title":"Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2625983628","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625983628?lang=en_us&edition=fundamental","pubTime":"2026-04-07 09:03","pubTimestamp":1775523780,"startTime":"0","endTime":"0","summary":"Strong growth in February/March following January seasonality Net revenue approaches US$100M since launch NEW YORK, April  06, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/07/3268787/0/en/Ryoncil-Continues-Successful-First-Year-Launch-with-Net-Sales-of-US-30-3M-in-March-Quarter.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MSB","MESO","BK4575","BK4006","MSC","BK4150"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174097776","title":"Airwallex Secures Dual Licenses for E-Money and MSB Class A Operations in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=1174097776","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174097776?lang=en_us&edition=fundamental","pubTime":"2026-04-01 11:00","pubTimestamp":1775012444,"startTime":"0","endTime":"0","summary":"Global fintech platform Airwallex has announced that it has obtained an e-money license and an MSB (Money Services Business) Class A license issued by Bank Negara Malaysia. This marks the final...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","MSB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624563915","title":"Press Release: Mesabi Metallics Secures $520 Million from Breakwall Capital - Advances towards Q3 2026 start of New American Iron Ore Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2624563915","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624563915?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:59","pubTimestamp":1774994340,"startTime":"0","endTime":"0","summary":"Financing supports U.S. critical mineral security and helps reshore the American steel supply chain. NASHWAUK, Minn., March 31, 2026 /PRNewswire/ -- Mesabi Metallics Company LLC , backed by the Essar Group, today announced that it has entered into a new $520 million senior secured credit facility with Valor Mining Credit Partners II, L.P. , a dedicated mining and critical minerals credit fund managed by Breakwall Capital LP  in partnership with Vitol, as it advances toward commercial operations later this year.Located on more than 16,000 acres in northern Minnesota, Mesabi Metallics is completing a $2.5 billion world-scale merchant Direct Reduction  grade iron ore mine and pellet plant that will onshore a strategically important segment of the U.S. steel supply chain.Mesabi Metallics Company LLC, an Essar Group company, is constructing a state-of-the-art mine and Direct","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB","BK4107","BK4117","AFG","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620578889","title":"Mesoblast (ASX:MSB) Valuation Check As First R&D Day Puts Pipeline And Growth Plans In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2620578889","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620578889?lang=en_us&edition=fundamental","pubTime":"2026-03-20 13:10","pubTimestamp":1773983450,"startTime":"0","endTime":"0","summary":"Mesoblast (ASX:MSB) is drawing fresh attention after announcing its inaugural R&D Day in New York City on April 8, 2026. At the event, leadership and external experts will outline corporate strategy and pipeline plans.\nSee our latest analysis for Mesoblast.\nThose R&D Day plans come after a tough stretch for the share price, with a 30 day share price return of a 14.11% decline and a year to date share price return of a 25.27% decline, even though the three year total shareholder return is up...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-first-rd-day-puts-pipeli","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-asxmsb-valuation-check-as-first-rd-day-puts-pipeli","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7501","BK7508","BK7067","BK4006","MSB.AU","MSB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":46,"code":"91000000","status":"200"}]}}